Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Delivery is Scopus-indexed (Q2, CiteScore 3.8), WoS ESCI. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2041-5990Verify ISSN ↗2041-6008Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 85 / 191 | 55th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q2, CiteScore 3.8.
Therapeutic Delivery is Q2 in Pharmaceutical Science (rank 85 of 191), by CiteScore 2025.
Therapeutic Delivery is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.8, which places it in quartile Q2 at the 55th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.462, quartile Q2, with an H-index of 74.
Therapeutic Delivery is published by Taylor and Francis Ltd. Its print ISSN is 2041-5990 and its online ISSN is 2041-6008.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Therapeutic Delivery has an h-index of 81 and a 2-year mean of 3.48 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q2. On 2-year citations it ranks #55 of 177 Scopus journals in Pharmaceutical Science.
Therapeutic Delivery published 86 papers in 2025; its busiest recent year was 2017 with 103. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from India (39.3%), United States (11.1%) and Iran (5.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.